Page last updated: 2024-08-21

diphenyldiselenide and Dyslipidemias

diphenyldiselenide has been researched along with Dyslipidemias in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, H; Huan, Y; Huang, K; Ji, W; Lei, L; Li, C; Liu, Q; Liu, S; Shen, Z; Sun, S; Wang, X; Zhou, J	1

Other Studies

1 other study(ies) available for diphenyldiselenide and Dyslipidemias

Article	Year
Diphenyl diselenide ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats via suppressing oxidative stress and inflammation. Chemico-biological interactions, 2021, Apr-01, Volume: 338 Topics: Animals; Antioxidants; Benzene Derivatives; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dyslipidemias; Gene Expression Regulation; Glucose; Inflammation; Kelch-Like ECH-Associated Protein 1; Kidney; Lipid Metabolism; Male; MAP Kinase Signaling System; Models, Biological; NF-E2-Related Factor 2; NF-kappa B; Organoselenium Compounds; Oxidative Stress; Rats, Sprague-Dawley; Streptozocin	2021

Article

Year

Diphenyl diselenide ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats via suppressing oxidative stress and inflammation.

Chemico-biological interactions, 2021, Apr-01, Volume: 338

Topics: Animals; Antioxidants; Benzene Derivatives; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dyslipidemias; Gene Expression Regulation; Glucose; Inflammation; Kelch-Like ECH-Associated Protein 1; Kidney; Lipid Metabolism; Male; MAP Kinase Signaling System; Models, Biological; NF-E2-Related Factor 2; NF-kappa B; Organoselenium Compounds; Oxidative Stress; Rats, Sprague-Dawley; Streptozocin

2021